- Supporting Healthcare Including Hospitals and Health Systems, Payers, and Pharma/Life Sciences Organizations.
- HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEzTM, DataEzTM.
- Company Positioned at Forefront of $208 Billion Global AI in Healthcare Market by 2030.
- Launched New SaaS Solutions to Drive Digital Transformation and AI Integration in Healthcare.
- New SaaS Allows Seamless Integration and Management of Data from Various Sources, Ensuring a Single Clear Source of Truth for all Patient Information.
Healthcare Triangle, Inc., (Nasdaq: HCTI) based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. HCTI supports healthcare including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on.
HCTI achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEzTM, DataEzTM and readabl.AI HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. HCTI enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on HCTI for expertise in digital transformation encompassing the cloud, security and compliance, identity management, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
Healthcare Triangle Unveils New SaaS Solutions to Drive Digital Transformation and AI Integration in Healthcare
On February 14th HCTI announced a groundbreaking move with the launch of a new SaaS solutions designed to spearhead digital transformation and AI integration in the healthcare sector. This strategic announcement positions HCTI at the forefront of driving innovation, aiming to revolutionize patient care, diagnostics, and treatment outcomes on a global scale.
The announcement also unveils the HCTI initiative to forge partnerships with prominent AI technology providers, healthcare, pharmaceutical, and research institutions. These collaborations aim to amplify the reach and expedite the realization of digital transformation goals in the global healthcare landscape.
The global healthcare sector is witnessing a rapid shift towards digital solutions, and the HCTI SaaS offerings are poised to play a pivotal role in shaping this evolution. The HCTI SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations. The HCTI SaaS solutions positions it at the forefront of pioneering advancements, as Grand View Research projects global AI in healthcare market is expected to reach $208.2 billion by 2030, indicating the immense potential for AI integration in transforming the healthcare landscape.
Technology solutions from HCTI not only streamline healthcare processes but also enable healthcare organizations to leverage the power of artificial intelligence for improved diagnostics, treatment planning, and overall patient care. The HCTI initiative aligns with the broader industry trends, reflecting a commitment to bridging the digital divide and making advanced healthcare technologies accessible to diverse populations.
The HCTI SaaS solutions, built on next-generation cloud technology, offer healthcare providers a robust platform for seamless data integration, advanced analytics, and streamlined operations. With the power of AI, these solutions can predict trends, automate routine tasks, and provide actionable insights, thereby revolutionizing the way healthcare is delivered.
Key features of HCTI’s new HCTI SaaS solutions include:
Interoperability and Seamless Integration: The HCTI SaaS solutions are designed with interoperability in mind, allowing healthcare providers to seamlessly integrate and manage data from various sources, ensuring a single clear source of truth for all patient-related information.
AI-Powered Clinical Decision Support: HCTI AI-powered SaaS solutions offer real-time, data-driven insights for enhanced clinical decision-making.
Predictive Analytics: Leveraging AI, the solutions can predict patient outcomes and help healthcare providers make informed decisions.
Patient-centric Engagement: HCTI SaaS solutions prioritize patient engagement by offering user-friendly interfaces and personalized experiences.
Automation: Routine tasks can be automated, freeing up valuable time for healthcare professionals to focus on patient care.
Security and Compliance: Built on secure cloud technology, the solutions ensure that all patient data is protected and compliant with healthcare regulations.
Global digital health venture capital funding reached $26.8 billion in 2022, showcasing the strong support and confidence investors have in the healthcare technology sector (Source: Global Health Innovation Index). The HCTI initiative leverages this confidence to drive digital health innovations that will revolutionize the industry.
With two billion people lacking access to essential health services, The HCTI initiative aims to address the digital divide, making technology solutions more inclusive and accessible (Source: World Health Organization). The HCTI commitment goes beyond profitability, focusing on creating solutions that cater to diverse global populations.
HCTI anticipates substantial investments in the healthcare sector, reaffirming its commitment to fostering continuous innovation and advancements in digital transformation. HCTI envisions a future where advanced healthcare technologies empower communities globally, irrespective of geographical or socio-economic constraints. Through this commitment, HCTI aims to play a transformative role in shaping the global healthcare landscape, ensuring equitable access to the benefits of healthcare technology across borders.
For more information on $HCTI visit: www.healthcaretriangle.com
DISCLAIMER:
CAP/FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CAP/FPS/CA is NOT affiliated in any manner with any company mentioned herein. CAP/FPS/CA is a news dissemination solutions provider and is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CAP/FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CAP/FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CAP/FPS/CA has been compensated $500 by a third party for dissemination of this article.
Disclaimer/Safe Harbor:
These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Media Contact
Company Name: Healthcare Triangle, Inc.
Contact Person: Dave Rosa, Chairman of the Board
Email: Send Email
Phone: 925 270 4812
Address:7901 Stoneridge Drive Suite 220
City: Pleasanton
State: California 94588
Country: United States
Website: https://www.healthcaretriangle.com/
